CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-12 | MCLAUGHLIN KEVIN F Director | Sale 10b5-1 | −7,000 | $44.53 | $312K | 18,300 |
| 2026-08-12 | MCLAUGHLIN KEVIN F Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | +7,000 | 7,000 | ||
| 2026-08-03 | Halpin Michael Chief Operating Officer | Option exercise 10b5-1 | +10,000 | $16.66 | $167K | 26,394 |
| 2026-08-03 | Halpin Michael Chief Operating Officer | Sale 10b5-1 | −10,000 | $46.84 | $468K | 16,394 |
| 2026-08-03 | Halpin Michael Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +10,000 | 26,250 | ||
| 2026-07-30 | SIEGAL JONATHAN Principal Accounting Officer | Option exercise 10b5-1 | +1,500 | $34.90 | $52K | 2,578 |
| 2026-07-30 | SIEGAL JONATHAN Principal Accounting Officer | Sale 10b5-1 | −1,500 | $48.90 | $73K | 1,078 |
| 2026-07-30 | SIEGAL JONATHAN Principal Accounting Officer | Option exercise 10b5-1 | +2,500 | $29.82 | $75K | 3,578 |
| 2026-07-30 | SIEGAL JONATHAN Principal Accounting Officer | Sale 10b5-1 | −2,500 | $48.90 | $122K | 1,078 |
| 2026-07-30 | SIEGAL JONATHAN Principal Accounting Officer | Option exercise 10b5-1 | +500 | $29.82 | $15K | 1,578 |
| 2026-07-30 | SIEGAL JONATHAN Principal Accounting Officer | Sale 10b5-1 | −500 | $48.90 | $24K | 1,078 |
| 2026-07-30 | SIEGAL JONATHAN Principal Accounting Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +1,500 | 2,698 | ||
| 2026-07-30 | SIEGAL JONATHAN Principal Accounting Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +2,500 | 4,000 | ||
| 2026-07-30 | SIEGAL JONATHAN Principal Accounting Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +500 | 3,500 | ||
| 2026-06-26 | SIEGAL JONATHAN Principal Accounting Officer | Sale 10b5-1 | −232 | $44.90 | $10K | 886 |
| 2026-06-26 | SIEGAL JONATHAN Principal Accounting Officer | Option exercise 10b5-1 | +2,500 | $29.82 | $75K | 3,386 |
| 2026-06-26 | SIEGAL JONATHAN Principal Accounting Officer | Sale 10b5-1 | −2,500 | $44.90 | $112K | 886 |
| 2026-06-26 | SIEGAL JONATHAN Principal Accounting Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +2,500 | 6,500 | ||
| 2026-06-26 | Mara Joseph Anthony Jr Chief Financial Officer | Sale 10b5-1 | −5,000 | $44.75 | $224K | 16,009 |
| 2026-06-26 | Hopper Jonathan Mark Chief Medical Officer | Option exercise 10b5-1 | +5,000 | $29.82 | $149K | 80,753 |
Page 3 of 75 · 1,497 trades